NBPE Announces November 2023 NAV Estimate
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- S&P 500 dips after Trump says Iran deal is 'over'
- Oil prices jump 7% as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
These 6 stocks are new Top Picks at Jefferies
December 20, 2023 3:51 PM ESTJefferies' Franchise Picks represent their analysts most confident, Buy-rated stocks within the research companys US Research portfolio. These top selections are backed by thorough analysis, distinct factors, and favorable valuations indicating potential for growth.
This month, Jefferies added 6 new ideas to the list.
argenx SE
argenx (NASDAQ: ARGX) was added to the list as Jefferies analysts consider the biotechnology companys s lead asset, Vyvgart, to be a best-in-class drug owing to its potent IgG drops, clean safety profile without dose-limiting albumin drops or effector-related adverse events, and convenient... More
